Objective. To provide a single source for the best available estimates of the US prevalence of
and number of individuals affected by arthritis overall, rheumatoid arthritis, juvenile arthritis, …

Scleroderma (systemic sclerosis) is associated with several autoantibodies, each of which
is useful in the diagnosis of affected patients and in determining their prognosis. Anti-…

To update and integrate the recommendations for ankylosing spondylitis and the recommendations
for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA…

Objective: To examine the clinical and radiographic features in men and women in the
Prospective Study of Outcomes in Ankylosing Spondylitis cohort, a large well-defined cross-…

Objective To evaluate the safety and efficacy of adalimumab, a fully human recombinant IgG1
monoclonal antibody that specifically targets human tumor necrosis factor, in patients with …

Ankylosing spondylitis is a common form of inflammatory arthritis predominantly affecting
the spine and pelvis that occurs in approximately 5 out of 1,000 adults of European descent. …

Objective To provide evidence‐based recommendations for the treatment of patients with
ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). Methods A core …

The following guideline presents a series of recommendations based on published medical
literature for use of the antinuclear antibody (ANA) test and tests for specific autoantibodies …

We have genotyped 14,436 nonsynonymous SNPs (nsSNPs) and 897 major histocompatibility
complex (MHC) tag SNPs from 1,000 independent cases of ankylosing spondylitis (AS), …

Genome-wide association studies have recently identified at least 15 susceptibility loci for
systemic lupus erythematosus (SLE). To confirm additional risk loci, we selected SNPs from …